Project Grant HT94252510731
Award Date 9/1/25
Completion Date 8/31/26
Dollars Obligated $736K
Federal Agency
Awardee
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Rochester, MN 55905, USA
Similar Awards
- The Department of Defense's Defense Health Agency awarded a $322,800 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the Mayo Clinic in Rochester, Minnesota. The grant, with a performance period from April 1, 2024 to March 31, 2026, supports research on "MYELOPEROXIDASE PROMOTES PERSISTENT FIBROSIS." As a renowned non-profit academic medical center, Mayo Clinic will leverage its expertise in clinical care, biomedical research, and medical...
- The U.S. Defense Health Agency has awarded a $1,187,875 Project Grant to Mayo Clinic to support the research project "INVESTIGATING MOLECULAR MECHANISMS UNDERLYING THE CILIARY TRAFFICKING OF POLYCYSTINS". This grant, awarded on April 1, 2024 under the Military Medical Research and Development program (CFDA 12.420), will fund research to advance the understanding of the molecular mechanisms involved in the trafficking of polycystins through cellular cilia. The project aims to yield...
- Mayo Clinic was awarded a $8,966,819 project grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will support research from July 1, 2023 to June 30, 2027 to further develop purified exosome products for treating pulmonary damage from toxic exposures, leveraging Mayo Clinic's expertise in exosome applications. Through this funding, Mayo Clinic aims to advance biomedical solutions applicable to both military and civilian...
- The Defense Health Agency awarded a $1,526,253 Project Grant to the Mayo Clinic in Rochester, Minnesota under the Military Medical Research and Development program (CFDA 12.420) on May 1, 2025. The grant, titled "Wearable Artificial Intelligence for Cardiac Function and Health Monitoring (WATCH) Study," will fund advanced biomedical research to develop innovative wearable technologies for comprehensive cardiac monitoring and health assessment of military personnel and the broader...
- The Defense Health Agency awarded a $152,192 Project Grant to Mayo Clinic in Rochester, MN under the Military Medical Research and Development program (CFDA 12.420) to develop a novel approach for the noninvasive molecular classification of kidney cancer using tumor-derived extracellular vesicles. The grant, with a performance period from November 1, 2025 to October 31, 2026, supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the...
- This $564,900.00 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research by Mayo Clinic in Rochester, MN. The project, titled "Targeting the Distinct Immune Microenvironments of Intrahepatic and Perihilar/Distal Cholangiocarcinoma," aims to transform healthcare for military service members, veterans, and the broader public through innovative and impactful research on a rare form...
- This federal Project Grant award from the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development) to Mayo Clinic provides $1,443,639.00 to investigate the molecular mechanisms underlying the ciliary trafficking of polycystins. The grant has an award date of April 1, 2024 and a planned completion date of March 31, 2028. This research seeks to advance the understanding of diseases related to ciliary dysfunction, which may have important implications for military medicine....
- The federal Project Grant award of $161,400.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) will support Mayo Clinic's research project titled "AN ATLAS OF THE TUMOR IMMUNE CIRCULOME." This award, with a performance period from June 1, 2024 to May 31, 2025, aims to advance medical knowledge and improve patient care through innovative biomedical research. The Military Medical Research and Development program funds a wide range of...
- The Department of the Army Medical Command awarded Mayo Clinic a $5,047,034 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund an evaluation of the cardiac and metabolic effects of semaglutide in heart failure patients with preserved ejection fraction from July 1, 2022 to June 30, 2026. Through support of basic, applied, and advanced biomedical research, the Military Medical Research and Development program aims to transform military...
- The Defense Health Agency awarded a $597,543.00 Project Grant to Mayo Clinic Arizona, doing business as Mayo Clinic Hospital, a nonprofit academic medical center. The grant, which runs from October 1, 2023 to September 14, 2026, is funded under the Military Medical Research and Development program (CFDA 12.420) to support research aimed at "elucidating mechanisms of CAR-T cell immunotherapy resistance and sensitivity to improve treatment of myeloma." As a nonprofit organization with...